Literature DB >> 18511704

Blunted hypoxic pulmonary vasoconstriction in experimental neonatal chronic lung disease.

Gloria Juliana Rey-Parra1, Stephen L Archer, Richard D Bland, Kurt H Albertine, David P Carlton, Soo-Chul Cho, Beth Kirby, Al Haromy, Farah Eaton, Xichen Wu, Bernard Thébaud.   

Abstract

RATIONALE: Neonatal chronic lung disease (CLD), caused by prolonged mechanical ventilation (MV) with O(2)-rich gas, is the most common cause of long-term hospitalization and recurrent respiratory illness in extremely premature infants. Recurrent episodes of hypoxemia and associated ventilator adjustments often lead to worsening CLD. The mechanism that causes these hypoxemic episodes is unknown. Hypoxic pulmonary vasoconstriction (HPV), which is partially controlled by O(2)-sensitive voltage-gated potassium (K(v)) channels, is an important adaptive response to local hypoxia that helps to match perfusion and ventilation in the lung.
OBJECTIVES: To test the hypothesis that chronic lung injury (CLI) impairs HPV.
METHODS: We studied preterm lambs that had MV with O(2)-rich gas for 3 weeks and newborn rats that breathed 95%-O(2) for 2 weeks, both of which resulted in airspace enlargement and pulmonary vascular changes consistent with CLD.
MEASUREMENTS AND MAIN RESULTS: HPV was attenuated in preterm lambs with CLI after 2 weeks of MV and in newborn rats with CLI after 2 weeks of hyperoxia. HPV and constriction to the K(v)1.x-specific inhibitor, correolide, were preferentially blunted in excised distal pulmonary arteries (dPAs) from hyperoxic rats, whose dPAs exhibited decreased K(v)1.5 and K(v)2.1 mRNA and K(+) current. Intrapulmonary gene transfer of K(v)1.5, encoding the ion channel that is thought to trigger HPV, increased O(2)-sensitive K(+) current in cultured smooth muscle cells from rat dPAs, and restored HPV in hyperoxic rats.
CONCLUSIONS: Reduced expression/activity of O(2)-sensitive K(v) channels in dPAs contributes to blunted HPV observed in neonatal CLD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511704      PMCID: PMC2542441          DOI: 10.1164/rccm.200711-1631OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  44 in total

1.  Abnormal lung function in healthy preterm infants.

Authors:  Ola Hjalmarson; Kenneth Sandberg
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

Review 2.  Bronchopulmonary dysplasia: "a vascular hypothesis".

Authors:  S H Abman
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

3.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

4.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

5.  Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes.

Authors:  O Platoshyn; Y Yu; V A Golovina; S S McDaniel; S Krick; L Li; J Y Wang; L J Rubin; J X Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-04       Impact factor: 5.464

6.  Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease.

Authors:  Sam Afshar; Linda L Gibson; Ivan S Yuhanna; Todd S Sherman; Jay D Kerecman; Peter H Grubb; Bradley A Yoder; Donald C McCurnin; Philip W Shaul
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01-10       Impact factor: 5.464

7.  Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance.

Authors:  R D Bland; K H Albertine; D P Carlton; L Kullama; P Davis; S C Cho; B I Kim; M Dahl; N Tabatabaei
Journal:  Pediatr Res       Date:  2000-07       Impact factor: 3.756

8.  Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs.

Authors:  A N MacRitchie; K H Albertine; J Sun; P S Lei; S C Jensen; A A Freestone; P M Clair; M J Dahl; E A Godfrey; D P Carlton; R D Bland
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-10       Impact factor: 5.464

9.  Mechanism of hypoxic pulmonary vasoconstriction involves ET(A) receptor-mediated inhibition of K(ATP) channel.

Authors:  K Sato; Y Morio; K G Morris; D M Rodman; I F McMurtry
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-03       Impact factor: 5.464

10.  In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.

Authors:  Zlatko I Pozeg; Evangelos D Michelakis; M Sean McMurtry; Bernard Thébaud; Xi-Chen Wu; Jason R B Dyck; Kyoko Hashimoto; Shaohua Wang; Rohit Moudgil; Gwyneth Harry; Richard Sultanian; Arvind Koshal; Stephen L Archer
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

View more
  4 in total

1.  Downregulated bone morphogenetic protein signaling in nitrofen-induced congenital diaphragmatic hernia.

Authors:  Martine Makanga; Céline Dewachter; Hidekazu Maruyama; Aline Vuckovic; Benoit Rondelet; Robert Naeije; Laurence Dewachter
Journal:  Pediatr Surg Int       Date:  2013-07-06       Impact factor: 1.827

2.  Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.

Authors:  Dalia Urboniene; Idith Haber; Yong-Hu Fang; Thenappan Thenappan; Stephen L Archer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-25       Impact factor: 5.464

Review 3.  PATET ratio by Doppler echocardiography: noninvasive detection of pediatric pulmonary arterial hypertension.

Authors:  Jennifer K Trittmann; Hanadi Almazroue; Leif D Nelin; Terri A Shaffer; Charanda R Celestine; Henry W Green; Raphael A Malbrue
Journal:  Pediatr Res       Date:  2021-11-18       Impact factor: 3.953

Review 4.  Oxygen therapy in preterm infants with pulmonary hypertension.

Authors:  Praveen Chandrasekharan; Satyan Lakshminrusimha
Journal:  Semin Fetal Neonatal Med       Date:  2019-12-03       Impact factor: 3.726

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.